0001104659-24-034102.txt : 20240313
0001104659-24-034102.hdr.sgml : 20240313
20240313212155
ACCESSION NUMBER: 0001104659-24-034102
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240311
FILED AS OF DATE: 20240313
DATE AS OF CHANGE: 20240313
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Griffin Jerry C
CENTRAL INDEX KEY: 0001327953
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38468
FILM NUMBER: 24747702
MAIL ADDRESS:
STREET 1: 887L INDUSTRIAL ROAD
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Inspire Medical Systems, Inc.
CENTRAL INDEX KEY: 0001609550
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 261377674
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5500 WAYZATA BLVD
STREET 2: SUITE 1600
CITY: GOLDEN VALLEY
STATE: MN
ZIP: 55416
BUSINESS PHONE: 763-957-5037
MAIL ADDRESS:
STREET 1: 5500 WAYZATA BLVD
STREET 2: SUITE 1600
CITY: GOLDEN VALLEY
STATE: MN
ZIP: 55416
4
1
tm248803-1_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-03-11
0
0001609550
Inspire Medical Systems, Inc.
INSP
0001327953
Griffin Jerry C
C/O INSPIRE MEDICAL SYSTEMS, INC.
5500 WAYZATA BLVD., SUITE 1600
GOLDEN VALLEY
MN
55416
1
0
0
0
1
Common Stock
2024-03-11
4
M
0
1000
16
A
10298
D
Common Stock
2024-03-11
4
S
0
54
198.05
D
10244
D
Common Stock
2024-03-11
4
S
0
500
198.05
D
9744
D
Stock Option (Right to Buy)
16
2024-03-11
4
M
0
1000
0
D
2028-05-02
Common Stock
1000
2296
D
The prior Form 4 for the Reporting Person dated March 5, 2024 contained a contained a computational error in the total number of securities beneficially owned following the reported transactions. The current total reflects the accurate number of shares held by the Reporting Person.
Reflects shares sold to cover taxes upon the option exercise pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 30, 2023 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 30, 2023 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
The option is fully vested and exercisable.
/s/ Bryan Phillips, as Attorney-in-Fact for Jerry C. Griffin
2024-03-13